Eleven Biotherapeutics, Inc.
New Filing
CIK: 0001485003·Biotechnology·DELAWARE·Filed: Feb 24, 2010
Total Offering
$35,000,000
Amount Sold
$4,500,000
Investors
2
First Sale
Feb 9, 2010
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506
- Entity Type
- Corporation
- Year Incorporated
- 2008
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Mark Levin | Related Person |
| David M Berry | Related Person |
| Noubar B. Afeyan | Related Person |
| Cary Pfeffer | Related Person |
| Kim C. Drapkin | Related Person |
Company
SEC Filing
0001485003-10-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free